{"id":"W2144510249","doi":"10.1177/1753465812452193","title":"New treatment options for multidrug-resistant tuberculosis","year":2012,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Tuberculosis; Isoniazid; Rifabutin; Linezolid; Intensive care medicine; Drug resistance; Mycobacterium tuberculosis; Rifampicin; Drug; Multiple drug resistance; Extensively drug-resistant tuberculosis; Adverse effect; Pyrazinamide; Public health; Pharmacology; Internal medicine; Microbiology; Pathology; Clarithromycin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003802139,0.0003393802,0.0005894012,0.0006859861,0.0003342212,0.0005914944,0.0006544277,0.0007896838,0.01790511],"category_scores_gemma":[0.0005465926,0.00009736297,0.0007583133,0.0004515226,0.0002796151,0.0009244728,0.0005576507,0.002229565,0.003729607],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002994847,"about_ca_system_score_gemma":0.0003833733,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003543605,"about_ca_topic_score_gemma":0.001223568,"domain_scores_codex":[0.9997998,0.00004233741,0.00001671773,0.0000314853,0.00007979601,0.00002992627],"domain_scores_gemma":[0.9998227,0.00003787609,0.00003517055,0.00001091491,0.00004514373,0.00004826648],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003845236,0.0005464944,0.0008730905,0.003506505,0.0001047883,0.001266538,0.000130295,0.0002991544,0.006068373,0.006867814,0.07762806,0.9023243],"study_design_scores_gemma":[0.0002911956,0.000707071,0.001713516,0.001660427,0.0001252929,0.003712016,0.00009833433,0.0003318565,0.00117292,0.005058566,0.9851016,0.00002727406],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007774505,0.9274743,0.00487762,0.01677801,0.004321938,0.0001686879,0.0003993141,0.0002133808,0.03799224],"genre_scores_gemma":[0.07139291,0.8515307,0.01230851,0.01909736,0.005899331,0.0003296412,0.001690486,0.00006972861,0.03768131],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01790511,"threshold_uncertainty_score":0.05989856,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1483258399282707,"score_gpt":0.4590051209546901,"score_spread":0.3106792810264195,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}